已关闭
  • 顶部Banner位
  • 固定模块
设置
BPD
试用
AI
企业管理端
厂家
MB21D1基因敲除细胞池(HAP1)
收藏 收藏
分享
原料试剂 研发实验室
价格
¥5499.00
品牌 粒曼生物
地区 中国,湖北省,武汉市
货号 LM01010164430
产地 国产
选择规格
1×10^6 cells/ 冻存管
易享客服
粒曼生物科技(武汉)有限公司
粒曼生物科技(武汉)有限公司
中国湖北武汉
营业执照已审核
粒曼生物专注于提供高通量细胞编辑解决方案,服务新药研发与基础科研。 粒曼生物是一家专注于高通量细胞编辑工具研发的技术驱动型公司,核心技术来自加州大学伯克利分校,公司已完成人全基因组19883个基因的敲除实验验证。基于粒曼工业智能化高通量体外细胞编辑平台,为客户提供基因敲除、过表达、点突变、原位/定点敲入定制服务及基因编辑细胞现货、基因敲除试剂盒等系列产品,助力新药研发与基础研究。 粒曼作为国内高通量基因敲除阵列文库领域的领导者,已建成自动化、高通量基因敲除平台,实现每月1000+ KO 细胞的生产产能。粒曼基于自身构建的 Harbor 细胞和 pCargo 质粒载体系统,实现 2 周高效构建稳定细胞系。
进入店铺
产品规格 图文详情 技术文档
产品规格
品牌名称
粒曼生物
货号
LM01010164430
国产/进口
国产
规格
1×10^6 cells/ 冻存管
货源
新品
图文详情

细胞基因敲除效率:100%

MB21D1 NCBI Gene ID:115004

MB21D1 Ensembl ID:ENSG00000164430

MB21D1 Uniprot ID:Q8N884

MB21D1 基因介绍:Nucleotidyltransferase that catalyzes the formation of cyclic GMP-AMP (cGAMP) from ATP and GTP and plays a key role in innate immunity (PubMed:23258413, PubMed:23707061, PubMed:23722159, PubMed:24077100, PubMed:25131990, PubMed:29976794, PubMed:30799039). Catalysis involves both the formation of a 2',5' phosphodiester linkage at the GpA step and the formation of a 3',5' phosphodiester linkage at the ApG step, producing c[G(2',5')pA(3',5')p] (PubMed:28363908, PubMed:28214358). Acts as a key cytosolic DNA sensor, the presence of double-stranded DNA (dsDNA) in the cytoplasm being a danger signal that triggers the immune responses (PubMed:28363908). Binds cytosolic DNA directly, leading to activation and synthesis of cGAMP, a second messenger that binds to and activates TMEM173/STING, thereby triggering type-I interferon production (PubMed:28363908, PubMed:28314590). Preferentially recognizes and binds curved long DNAs (PubMed:30007416). In contrast to other mammals, human CGAS displays species-specific mechanisms of DNA recognition and produces less cyclic GMP-AMP (cGAMP), allowing a more fine-tuned response to pathogens (PubMed:30007416). Has antiviral activity by sensing the presence of dsDNA from DNA viruses in the cytoplasm (PubMed:28363908). Also acts as an innate immune sensor of infection by retroviruses, such as HIV-1, by detecting the presence of reverse-transcribed DNA in the cytosol (PubMed:23929945). Detection of retroviral reverse-transcribed DNA in the cytosol may be indirect and be mediated via interaction with PQBP1, which directly binds reverse-transcribed retroviral DNA (PubMed:26046437). Also detects the presence of DNA from bacteria, such as M.tuberculosis (PubMed:26048138). cGAMP can be transferred from producing cells to neighboring cells through gap junctions, leading to promote TMEM173/STING activation and convey immune response to connecting cells (PubMed:24077100). cGAMP can also be transferred between cells by virtue of packaging within viral particles contributing to IFN-induction in newly infected cells in a cGAS-independent but TMEM173/STING-dependent manner (PubMed:26229115). In addition to antiviral activity, also involved in the response to cellular stresses, such as senescence, DNA damage or genome instability (PubMed:28738408, PubMed:28759889). Acts as a regulator of cellular senescence by binding to cytosolic chromatin fragments that are present in senescent cells, leading to trigger type-I interferon production via TMEM173/STING and promote cellular senescence (By similarity). Also involved in the inflammatory response to genome instability and double-stranded DNA breaks: acts by localizing to micronuclei arising from genome instability (PubMed:28738408, PubMed:28759889). Micronuclei, which as frequently found in cancer cells, consist of chromatin surrounded by its own nuclear membrane: following breakdown of the micronuclear envelope, a process associated with chromothripsis, CGAS binds self-DNA exposed to the cytosol, leading to cGAMP synthesis and subsequent activation of TMEM173/STING and type-I interferon production (PubMed:28738408, PubMed:28759889). Acts as a suppressor of DNA repair in response to DNA damage: translocates to the nucleus following dephosphorylation at Tyr-215 and inhibits homologous recombination repair by interacting with PARP1, the CGAS-PARP1 interaction leading to impede the formation of the PARP1-TIMELESS complex (PubMed:30356214).

细胞生长培养基:IMDM+10% FBS+1% P/S

细胞培养条件:37℃,5% CO2 的培养箱,1/3 到 1/5 传代

细胞倍增时间:~16 hours

细胞支原体检测结果:阴性

细胞开发路径:采用CRISPR-RNP方法生成稳定KO Cell Pool;Sanger 测序结果显示KO Cell Pool敲除效率>70%

细胞应用:高敲除效率的基因敲除细胞池(KO Cell Pool),特别适用于初步功能分析、复杂疾病模型的开发、精准药物筛选以及广泛的基因发现研究。

技术文档
没有您想要的资料?去索要
返回顶部